Carcinoma of bladder
|
|
0.020 |
GeneticVariation
|
BEFREE |
UDP-glucuronosyltransferase 2B7 C802T (His268Tyr) polymorphism in bladder cancer cases.
|
18569595 |
2008 |
Malignant neoplasm of urinary bladder
|
|
0.020 |
GeneticVariation
|
BEFREE |
UDP-glucuronosyltransferase 2B7 C802T (His268Tyr) polymorphism in bladder cancer cases.
|
18569595 |
2008 |
Bladder Neoplasm
|
|
0.020 |
GeneticVariation
|
BEFREE |
UDP-glucuronosyltransferase 2B7 C802T (His268Tyr) polymorphism in bladder cancer cases.
|
18569595 |
2008 |
Carcinoma of bladder
|
|
0.020 |
GeneticVariation
|
BEFREE |
An association of UDP-glucuronosyltransferase 2B7 C802T (His268Tyr) polymorphism with bladder cancer in benzidine-exposed workers in China.
|
15615884 |
2005 |
Bladder Neoplasm
|
|
0.020 |
GeneticVariation
|
BEFREE |
An association of UDP-glucuronosyltransferase 2B7 C802T (His268Tyr) polymorphism with bladder cancer in benzidine-exposed workers in China.
|
15615884 |
2005 |
Malignant neoplasm of urinary bladder
|
|
0.020 |
GeneticVariation
|
BEFREE |
An association of UDP-glucuronosyltransferase 2B7 C802T (His268Tyr) polymorphism with bladder cancer in benzidine-exposed workers in China.
|
15615884 |
2005 |
Epilepsy
|
|
0.010 |
GeneticVariation
|
BEFREE |
Single nucleotide polymorphisms UGT1A4 142T > G, L48V (*3), UGT1A4 70C > A, P24T (*2) and UGT2B7 802C > T, H268Y (*2) were determined in 40 women (47 pregnancies) with epilepsy treated with LTG.
|
29395496 |
2018 |
Breast Carcinoma
|
|
0.010 |
GeneticVariation
|
BEFREE |
Impact of UGT2B7 His268Tyr polymorphism on the outcome of adjuvant epirubicin treatment in breast cancer.
|
21658222 |
2011 |
Malignant neoplasm of breast
|
|
0.010 |
GeneticVariation
|
BEFREE |
Impact of UGT2B7 His268Tyr polymorphism on the outcome of adjuvant epirubicin treatment in breast cancer.
|
21658222 |
2011 |
Colorectal Carcinoma
|
|
0.010 |
GeneticVariation
|
BEFREE |
To determine whether a genetic polymorphism in the detoxification enzyme UDP-glucuronosyltransferase 2B7 (UGT2B7) predisposes to CRC, 411 Caucasian patients with sporadic CRC and 600 Caucasian controls recruited from the same geographic area were genotyped for the functional UGT2B7 H268Y polymorphism.
|
19408577 |
2009 |
Neoplasms
|
|
0.010 |
GeneticVariation
|
BEFREE |
Polymorphic variation in five UGT and SULT genes - UGT1A1 ((TA)6/(TA)7), UGT2B4 (Asp458Glu), UGT2B7 (His268Tyr), UGT2B15 (Asp85Tyr), and SULT1A1 (Arg213His)--may be associated with circulating sex hormone concentrations, or the risk of an estrogen receptor-negative (ER-) or progesterone receptor-negative (PR-) tumor.
|
15318931 |
2004 |
Malignant Neoplasms
|
|
0.010 |
GeneticVariation
|
BEFREE |
Morphine glucuronide-to-morphine plasma ratios are unaffected by the UGT2B7 H268Y and UGT1A1*28 polymorphisms in cancer patients on chronic morphine therapy.
|
12185559 |
2002 |
Primary malignant neoplasm
|
|
0.010 |
GeneticVariation
|
BEFREE |
Morphine glucuronide-to-morphine plasma ratios are unaffected by the UGT2B7 H268Y and UGT1A1*28 polymorphisms in cancer patients on chronic morphine therapy.
|
12185559 |
2002 |